Net Loss Per Share (Details) - shares |
6 Months Ended | |
|---|---|---|
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | ||
| Total (in shares) | 17,637,597 | 17,623,988 |
| Stock options | ||
| Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | ||
| Total (in shares) | 14,528,184 | 14,992,091 |
| Unvested RSUs | ||
| Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | ||
| Total (in shares) | 2,790,997 | 2,183,873 |
| Estimated shares of common stock expected to be purchased under the ESPP | ||
| Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | ||
| Total (in shares) | 283,573 | 444,624 |
| Stock held in trust under deferred compensation plan | ||
| Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] | ||
| Total (in shares) | 34,843 | 3,400 |